Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 111, Issue 1, 112-121, January 1, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
Blood Buitenhuis et al. 111: 112

Supplemental materials for: Buitenhuis et al

Files in this Data Supplement:

  • Figure S1. Regulation of PKB activity regulates granulopoiesis (PDF, 16 KB) -
    (A) CD34+ cells were cultured in presence of (A) G-CSF to induce neutrophil differentiation during 17 days or (B) IL-5 to induce eosinophil development. Cells were cultured either in absence or presence of 10 µM LY294002 or 20 µM 1L-6-Hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (HIMO) a PKB inhibitor. After 17 days of neutrophil differentiation, cytospins were made and stained with May-Grunwald Giemsa solution. Data was depicted as the percentage of progenitors, eosinophils, neutrophils and monocytes. (C/D) CD34+ cells were retrovirally transduced with myrPKB, PKBcaax or eGFP alone. Retrovirally transduced CD34+ cells were cultured in presence of (C) G-CSF to induce neutrophil differentiation or (D) IL-5 to induce eosinophil development. After 17 days of culture, transduced cells were separated from the non-transduced cells by FACS, and cytospins were made. Cytospins were stained with May-Grunwald Giemsa solution. Data was expressed as the percentage of progenitors, eosinophils, neutrophils and monocytes.

  • Figure S2. Expression profiles in transduced cells (PDF, 51 KB) -
    (A) CD34+ cells were retrovirally transduced with eGFP as a control (lane 1), myrPKB (lane 2) or PKBcaax (lane 3). After 7 days of differentiation in presence of G-CSF to induce neutrophil differentiation, transduced cells were separated from the non-transduced cells by FACS, and protein lysates were made. Western Blot analysis was performed with antibodies against phosphorylated PKB (Ser473), PKB and -actin. (B) CD34+ cells were retrovirally transduced with eGFP as a control (lane 1) or GSK3CA (lane 2). After 7 days of differentiation in presence of IL-3 and IL-5 to induce eosinophil differentiation, transduced cells were separated from the non-transduced cells by FACS, and protein lysates were made. Western Blot analysis was performed with antibodies against GSK-3 and Tubulin (C). CD34+ cells were retrovirally transduced with eGFP as a control (lane 1), wild C/EBP (lane 2), or C/EBPT222/226A (lane 3). After 10 days of differentiation in presence of IL-3 and IL-5 to induce eosinophil differentiation, transduced cells were separated from the non-transduced cells by FACS, and protein lysates were made. Western Blot analysis was performed with antibodies against phosphorylated C/EBP (T221/226), C/EBP and Tubulin.

  • Figure S3. Modulation of PI3K/PKB regulates downstream effectors of PKB in granulocytic progenitors (PDF, 36 KB) -
    (A) CD34+ cells were cultured in presence of G-CSF for 10 days to induce neutrophil differentiation. Cells were left untreated (lane 1) or treated with 10 µM LY294002 for 16 hours (lane 2) before protein lysates were made. Western Blot analysis was performed with antibodies against phosphorylated GSK3 (Ser9), phosphorylated S6(Ser235/236), and, as a control for equal loading, Tubulin. (B) CD34+ cells were retrovirally transduced with eGFP as a control (lane 1), or myrPKB (lane 2). After 7 days of differentiation in presence of IL-3 and IL-5 to induce eosinophil differentiation, transduced cells were separated from the non-transduced cells by FACS, and protein lysates were made. Western Blot analysis was performed with antibodies against phosphorylated PKB(Ser473), phosphorylated S6(235/236) and Tubulin.




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020